Quanming Zou

Expression, purification, and characterization of recombinant human interleukin 24 in Escherichia coli.

[Techniques of separation and identification of enterohemorrhagic Escherichia coli O157 in laboratory].

Engineering an anti-Stx2 antibody to control severe infections of EHEC O157:H7.

Functional identification of HugZ, a heme oxygenase from Helicobacter pylori.

Identification of small noncoding RNAs in Helicobacter pylori by a bioinformatics-based approach.

Enterohemorrhagic Escherichia coli trivalent recombinant vaccine containing EspA, intimin and Stx2 induces strong humoral immune response and confers protection in mice.

Cloning a truncated fragment (stx2a(1)) of the shiga-like toxin 2A (1) subunit of EHEC O157:H7: candidate immunogen for a subunit vaccine.

Protection from high-fat-diet-induced impaired glucose tolerance in female Sprague-Dawley rats.

Crystallization and preliminary crystallographic studies of a flavin-dependent thymidylate synthase from Helicobacter pylori.

Up-regulated microRNA-146a negatively modulate Helicobacter pylori-induced inflammatory response in human gastric epithelial cells.

Crystallization and preliminary crystallographic studies of the C-terminal domain of outer membrane protein A from enterohaemorrhagic Escherichia coli.

Characterization of enterohemorrhagic Escherichia coli O157:H7 00B015: a Shiga toxin producing but virulence-attenuated isolate.

Fusion expression and immunogenicity of Bordetella pertussis PTS1-FHA protein: implications for the vaccine development.

Crystal structure of HugZ, a novel heme oxygenase from Helicobacter pylori.

Crystal structure of EHEC intimin: insights into the complementarity between EPEC and EHEC.

Crystallization and preliminary X-ray studies of native and mutant intimin from enterohaemorrhagic Escherichia coli.

Expression, crystallization and preliminary crystallographic study of octaprenyl pyrophosphate synthase from Helicobacter pylori.

Crystallization and preliminary crystallographic studies of Helicobacter pylori arginase.

Vaccination of attenuated EIS-producing Salmonella induces protective immunity against enterohemorrhagic Escherichia coli in mice.

Genotyping analysis of Helicobacter pylori using multiple-locus variable-number tandem-repeats analysis in five regions of China and Japan.

Crystal structure of Campylobacter jejuni ChuZ: a split-barrel family heme oxygenase with a novel heme-binding mode.

Expression, purification and characterization of arginase from Helicobacter pylori in its apo form.

Crystallization and preliminary crystallographic studies of Campylobacter jejuni ChuZ, a member of a novel haem oxygenase family.

Identification of antigen-specific antibody responses associated with upper genital tract pathology in mice infected with Chlamydia muridarum.

Mapping immunodominant antigens and H-2-linked antibody responses in mice urogenitally infected with Chlamydia muridarum.

Crystal structure of a flavin-dependent thymidylate synthase from Helicobacter pylori strain 26695.

Increased circulating Th22 and Th17 cells are associated with tumor progression and patient survival in human gastric cancer.

Genome of Helicobacter pylori strain XZ274, an isolate from a tibetan patient with gastric cancer in China.

Crystal structure of TNF-α-inducing protein from Helicobacter pylori in active form reveals the intrinsic molecular flexibility for unique DNA-binding.

Identification of a novel linear epitope in tetanus toxin recognized by a protective monoclonal antibody: implications for vaccine design.

Modeling studies with Helicobacter pylori octaprenyl pyrophosphate synthase reveal the enzymatic mechanism of trans-prenyltransferases.

Helicobacter pylori chaperone-like protein CagT plays an essential role in the translocation of CagA into host cells.

Development and characterization of a novel nanoemulsion drug-delivery system for potential application in oral delivery of protein drugs.

Structural, enzymatic and biochemical studies on Helicobacter pylori arginase.

A novel gastroretentive porous microparticle for anti-Helicobacter pylori therapy: preparation, in vitro and in vivo evaluation.

Efficacy and pharmacological mechanism of pronase-enhanced low-dose antibiotics for Helicobacter pylori eradication.

Anti-helicobacter pylori effect of total alkaloids of sophora alopecuroides in vivo.

Immunodominant CD4+ T-cell responses to influenza A virus in healthy individuals focus on matrix 1 and nucleoprotein.

Outer membrane inflammatory protein A, a new virulence factor involved in the pathogenesis of Helicobacter pylori.

Trastuzumab triggers phagocytic killing of high HER2 cancer cells in vitro and in vivo by interaction with Fcγ receptors on macrophages.

Intranasal immunization with an epitope-based vaccine results in earlier protection, but not better protective efficacy, against Helicobacter pylori compared to subcutaneous immunization.

Immunization with Heat Shock Protein A and γ-Glutamyl Transpeptidase Induces Reduction on the Helicobacter pylori Colonization in Mice.

Efficacy, safety, and immunogenicity of an oral recombinant Helicobacter pylori vaccine in children in China: a randomised, double-blind, placebo-controlled, phase 3 trial.

Immunodominant epitope-specific Th1 but not Th17 responses mediate protection against Helicobacter pylori infection following UreB vaccination of BALB/c mice.

Protective Efficacy and Mechanism of Passive Immunization with Polyclonal Antibodies in a Sepsis Model of Staphylococcus aureus Infection.

Induction of systemic and mucosal immunity against methicillin-resistant Staphylococcus aureus infection by a novel nanoemulsion adjuvant vaccine.

Biochemical and functional characterization of the periplasmic domain of the outer membrane protein A from enterohemorrhagic Escherichia coli.

A novel nitro-dexamethasone inhibits agr system activity and improves therapeutic effects in MRSA sepsis models without antibiotics.

Protective efficacy of the chimeric Staphylococcus aureus vaccine candidate IC in sepsis and pneumonia models.

Enhanced efficacy and anti-biofilm activity of novel nanoemulsions against skin burn wound multi-drug resistant MRSA infections.

Systematic identification of immunodominant CD4+ T cell responses to HpaA in Helicobacter pylori infected individuals.

Lachnospiraceae shift in the microbial community of mice faecal sample effects on water immersion restraint stress.

Broad-Based CD4 T Cell Responses to Influenza A Virus in a Healthy Individual Who Lacks Typical Immunodominance Hierarchy.

Protective Efficacy of the Trivalent Pseudomonas aeruginosa Vaccine Candidate PcrV-OprI-Hcp1 in Murine Pneumonia and Burn Models.

Vaccination with a recombinant OprL fragment induces a Th17 response and confers serotype-independent protection against Pseudomonas aeruginosa infection in mice.

The influence of adjuvant on UreB protection against through the diversity of CD4+ T-cell epitope repertoire.

A novel bivalent fusion vaccine induces broad immunoprotection against Staphylococcus aureus infection in different murine models.

Immunization with Pseudomonas aeruginosa outer membrane vesicles stimulates protective immunity in mice.

Immunodominant antigens that induce Th1 and Th17 responses protect mice against infection.

PA0833 Is an OmpA C-Like Protein That Confers Protection Against Infection.

Rational Design and Evaluation of an Artificial K1 Protein Vaccine Candidate Based on the Structure of OmpA.

An immunopotentiator, ophiopogonin D, encapsulated in a nanoemulsion as a robust adjuvant to improve vaccine efficacy.

Chitosan-polyvinyl alcohol nanoscale liquid film-forming system facilitates MRSA-infected wound healing by enhancing antibacterial and antibiofilm properties.

Development of a safety and efficacy nanoemulsion delivery system encapsulated gambogic acid for acute myeloid leukemia in vitro and in vivo.

Degranulation of mast cells induced by gastric cancer-derived adrenomedullin prompts gastric cancer progression.

A lethal pneumonia model of Acinetobacter baumannii: an investigation in immunocompetent mice.

The miR-29c-KIAA1199 axis regulates gastric cancer migration by binding with WBP11 and PTP4A3.

Epitope-loaded nanoemulsion delivery system with ability of extending antigen release elicits potent Th1 response for intranasal vaccine against Helicobacter pylori.

Helicobacter pylori-downregulated tumor necrosis factor receptor-associated protein 1 mediates apoptosis of human gastric epithelial cells.

Increased intratumoral mast cells foster immune suppression and gastric cancer progression through TNF-α-PD-L1 pathway.

Rational Design of a Chimeric Derivative of PcrV as a Subunit Vaccine Against .

Prophylactic and therapeutic protection of human IgG purified from sera containing anti-exotoxin A titers against pneumonia caused by .

Rapid and Broad Immune Efficacy of a Recombinant Five-Antigen Vaccine against Infection in Animal Models.

Progress and Prospects on Vaccine Development against SARS-CoV-2.

Determining the immunological characteristics of a novel human monoclonal antibody developed against staphylococcal enterotoxin B.

Toll-like receptors: Triggers of regulated cell death and promising targets for cancer therapy.

Host CD8α and CD103 dendritic cells prime transplant antigen-specific CD8 T cells via cross-dressing.

Expression of ETS1 in gastric epithelial cells positively regulate inflammatory response in Helicobacter pylori-associated gastritis.

PD-1 does not mark tumor-infiltrating CD8+ T cell dysfunction in human gastric cancer.

Complete Genome Sequence of Pseudomonas aeruginosa XN-1, Isolated from the Sputum of a Severe Pneumonia Patient.

The efficacy assessment of convalescent plasma therapy for COVID-19 patients: a multi-center case series.

Genome Sequence of Klebsiella pneumoniae YBQ, a Clinical Strain Isolated from the Sputum of a Patient with Severe Pneumonia.

HtrA family proteases of bacterial pathogens: pros and cons for their therapeutic use.

Development of a Chimeric Vaccine Against Based on the Th17-Stimulating Epitopes of PcrV and AmpC.

Development of a chitosan-modified PLGA nanoparticle vaccine for protection against Escherichia coli K1 caused meningitis in mice.

Flagella hook protein FlgE is a novel vaccine candidate of Pseudomonas aeruginosa identified by a genomic approach.

Identification and application of a neutralizing epitope within alpha-hemolysin using human serum antibodies elicited by vaccination.

A novel self-assembled epitope peptide nanoemulsion vaccine targeting nasal mucosal epithelial cell for reinvigorating CD8 T cell immune activity and inhibiting tumor progression.

Immunodominance of Epitopes and Protective Efficacy of HI Antigen Are Differentially Altered Using Different Adjuvants in a Mouse Model of Bacteremia.

Vaccination induces rapid protection against bacterial pneumonia via training alveolar macrophage in mice.

High-throughput screening and evaluation of repurposed drugs targeting the SARS-CoV-2 main protease.

α-Hemolysin-Aided Oligomerization of the Spike Protein RBD Resulted in Improved Immunogenicity and Neutralization Against SARS-CoV-2 Variants.

HIV-1 Vif suppresses antiviral immunity by targeting STING.

Disulfiram Enhances the Activity of Polymyxin B Against by Inhibiting Lipid A Modification.

Identification and Application of a Panel of Constitutive Promoters for Gene Overexpression in .

Evaluation of a recombinant five-antigen Staphylococcus aureus vaccine: The randomized, single-centre phase 1a/1b clinical trials.

Immune response effects of diverse vaccine antigen attachment ways based on the self-made nanoemulsion adjuvant in systemic MRSA infection.

Protective effects of a nanoemulsion adjuvant vaccine (2C-Staph/NE) administered intranasally against invasive pneumonia.

Calreticulin enhances gastric cancer metastasis by dimethylating H3K9 in the E-cadherin promoter region mediating by G9a.

A lipophilic chitosan-modified self-nanoemulsifying system influencing cellular membrane metabolism enhances antibacterial and anti-biofilm efficacy for multi-drug resistant Pseudomonas aeruginosa wound infection.

Extracellular fibrinogen-binding protein released by intracellular Staphylococcus aureus suppresses host immunity by targeting TRAF3.

Respiratory mucosal vaccination of peptide-poloxamine-DNA nanoparticles provides complete protection against lethal SARS-CoV-2 challenge.